Journal of the National Comprehensive Cancer Network

Papers
(The H4-Index of Journal of the National Comprehensive Cancer Network is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology892
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology737
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology691
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021647
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology626
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology515
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology514
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology481
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology391
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology332
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021306
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology304
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology293
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology285
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022232
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021205
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021198
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology193
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology190
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021190
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023188
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology179
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021177
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022158
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology157
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022148
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023143
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology140
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology136
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology128
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology121
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021118
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022104
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021100
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology99
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.202198
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.202273
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.202272
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.202272
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology69
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.202266
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.202353
NCCN Guidelines® Insights: Palliative Care, Version 2.202152
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.202452
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.202350
Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology49
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.202247
0.11439800262451